NHS Approves New Treatment for 530 Boys with Duchenne

Boys living with Duchenne muscular dystrophy in England now have access to a new treatment that could extend their ability to walk by up to five years.

The NHS has approved givinostat, offering fresh hope to families facing this devastating muscle-wasting disease.